- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
March 8th, 2010
NanoViricides to raise $40M through occasional stock sales
Drug maker NanoViricides Inc. has filed documents stating that it will look to raise up to $40 million through the occasional sale of company stock, for as-yet undefined general corporate purposes.
The shelf registration statement filed with the U.S. Securities and Exchange Commission has not yet become effective, officials said, so no immediate offering has begun. The registration covers a sale period of three years.
|Related News Press|
News and information
Attosecond physics: Mapping electromagnetic waveforms July 25th, 2016
Nanometrics Announces Upcoming Investor Events July 20th, 2016
Accurate design of large icosahedral protein nanocages pushes bioengineering boundaries: Scientists used computational methods to build ten large, two-component, co-assembling icosahedral protein complexes the size of small virus coats July 25th, 2016